Wear it pink on 24 October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Home About us Media Breast Cancer Now media statements 215 results Responding to new research that pembrolizumab cuts the risk of triple negative breast cancer returning by 37% 10 Feb 2022 1 min read We respond to House of Commons library analysis revealing record numbers of women facing delays to see an NHS cancer specialist 07 Feb 2022 1 min read We respond to Professor Gilbert’s talk at UK Interdisciplinary Breast Cancer Symposium, surrounding ‘Personalised breast cancer screening’ 31 Jan 2022 1 min read Responding to a new AI tool being tested to establish HER2 status in breast cancer 19 Jan 2022 1 min read We welcome the SMC’s approval of two new treatments for use on the NHS in Scotland- trastuzumab deruxtecan (Enhertu) and tucatinib (Tukysa) in combination with trastuzumab and capecitabine 17 Jan 2022 3 min read We respond to NHS England breast cancer waiting times: November 2021 13 Jan 2022 2 min read We respond to a new study showing how some cancer cells are able to resist PARP inhibitor drugs 11 Jan 2022 1 min read We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read Responding to new research into the impact of dairy on breast cancer risk 17 Nov 2021 1 min read We respond to NHS England breast cancer waiting times: September 2021 11 Nov 2021 2 min read Previous 1 ... 14 ... 18 Next
Responding to new research that pembrolizumab cuts the risk of triple negative breast cancer returning by 37% 10 Feb 2022 1 min read
We respond to House of Commons library analysis revealing record numbers of women facing delays to see an NHS cancer specialist 07 Feb 2022 1 min read
We respond to Professor Gilbert’s talk at UK Interdisciplinary Breast Cancer Symposium, surrounding ‘Personalised breast cancer screening’ 31 Jan 2022 1 min read
Responding to a new AI tool being tested to establish HER2 status in breast cancer 19 Jan 2022 1 min read
We welcome the SMC’s approval of two new treatments for use on the NHS in Scotland- trastuzumab deruxtecan (Enhertu) and tucatinib (Tukysa) in combination with trastuzumab and capecitabine 17 Jan 2022 3 min read
We respond to a new study showing how some cancer cells are able to resist PARP inhibitor drugs 11 Jan 2022 1 min read
We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read
We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read
We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read
